In order to evaluate LOX-1 expression in clear cell renal carcinoma at different grades and stages, immunohistochemistry was performed on 40 human clear cell renal cancer tissues; healthy tissues aside the neoplasia (called Normal peritumoral Tissue; NpT) from the same patients were also examined. This evidence concerns the gene OLR1 and neoplasm.